Company Profile
To Our Shareholders On the Threshold of Success KOS:An Emerging Player
Building the Future Financials Corporate Information

Corporate Information

CORPORATE HEADQUARTERS

1001 Brickell Bay Drive, 25th Floor
Miami, Florida 33131-4940
(305) 577-3464
(305) 577-4596 Fax
www.kospharm.com


SHAREHOLDER INFORMATION

Shareholder information and a copy of the Company’s
Annual Report on Form 10-K, as filed with the Securities
and Exchange Commission, may be obtained free
of charge by contacting the Company at (305) 577-3464.


TRANSFER AGENT

American Stock Transfer & Trust Company
Shareholder Relations Department
40 Wall Street, 46th Floor
New York, New York 10005
(800) 937-5449
(718) 236-2641 Fax


INDEPENDENT ACCOUNTANTS

Arthur Andersen LLP
One Biscayne Tower, Suite 2100
Miami, Florida 33131-1801


CORPORATE COUNSEL

Holland & Knight LLP
701 Brickell Avenue, Suite 3000
Miami, Florida 33131-5441


ANNUAL MEETING

The Annual Meeting of Shareholders will be held on
Thursday, April 15, 1999, at 10:00 a.m. local time,
at the Hyatt Regency Coral Gables, 50 Alhambra Plaza,
Coral Gables, Florida. Shareholders are cordially invited
to attend.

CORPORATE OFFICERS

Daniel M. Bell
President and Chief Executive Officer

Robert E. Baldini
Vice Chairman of the Board and
  Chief Sales and Marketing Officer

David J. Bova
Senior Vice President,
  Research and Development

Duncan H. Cocroft
Senior Vice President,
  Chief Administrative Officer

Marvin F. Blanford, Pharm. D.
Vice President, Compliance

Eugenio A. Cefali, Pharm. D., Ph.D.
Vice President, Clinical Pharmacology

Anthony J. Cutie, Ph.D.
Vice President,
  Aerosol Research and Development

David L. Heatherman
Vice President, Sales

Mark E. McGovern, M.D.
Vice President, Medical Affairs

Mukesh P. Patel
Vice President, Licensing

Frederick A. Sexton
Vice President, Technical Operations

Juan F. Rodriguez
Controller and Secretary

BOARD OF DIRECTORS

Michael Jaharis
Chairman of the Board

Daniel M. Bell
President and Chief Executive Officer

Robert E. Baldini
Vice Chairman of the Board and
  Chief Sales and Marketing Officer

John Brademas, Ph.D.
President Emeritus of
  New York University

Steven Jaharis, M.D.
Family Practitioner,
  Evanston Northwestern Healthcare

Louis C. Lasagna, M.D.
Dean of Sackler School of
  Graduate Biomedical Sciences,
  Tufts University

Mark Novitch, M.D.
Professor of Health Care Sciences,
  George Washington University

Frederick B. Whittemore
Advisory Director,
  Morgan Stanley Group